Topical interleukin-8 antibody attracts leukocytes in a piglet lavage model

Intensive Care Medicine

Volumn 31, Issue 2, 2005, Pages 272-280

  Ankermann, Tobias ^a   Wiemann, Tina ^a   Reisner, Anja ^a   Orlowska Volk, Marzenna ^b   Köhler, Heike ^c   Krause, Martin F ^a  

^a UNIVERSITY OF KIEL   (Germany)

^b UNIVERSITY OF FREIBURG   (Germany)

^c FEDERAL RESEARCH INSTITUTE FOR ANIMAL HEALTH   (Germany)

Author keywords

Airway lavage; Inflammation; Interleukin 8 antibody; Lung function; Migration; Polymorphonuclear leukocytes

Indexed keywords

INTERLEUKIN 8; INTERLEUKIN 8 ANTIBODY; LUNG SURFACTANT; OXYGEN;

AIRWAY; ANESTHESIA; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ARTIFICIAL VENTILATION; CELL MIGRATION; CONTROLLED STUDY; CYTOKINE PRODUCTION; DRUG EFFECT; DRUG POTENCY; FEMALE; LAVAGE; LEUKOCYTE; LUNG FUNCTION; LUNG INJURY; LUNG PARENCHYMA; MALE; NONHUMAN; OXYGENATION; PNEUMONIA; PROSPECTIVE STUDY; RANDOMIZATION; SWINE;

ADMINISTRATION, TOPICAL; ANALYSIS OF VARIANCE; ANIMALS; ANIMALS, NEWBORN; BRONCHOALVEOLAR LAVAGE; BRONCHOALVEOLAR LAVAGE FLUID; IMMUNOGLOBULIN G; INTERLEUKIN-8; LINEAR MODELS; LUNG COMPLIANCE; NEUTROPHILS; PROSPECTIVE STUDIES; PULMONARY SURFACTANTS; RANDOM ALLOCATION; RESPIRATION, ARTIFICIAL; RESPIRATORY FUNCTION TESTS; RESPIRATORY INSUFFICIENCY; STATISTICS, NONPARAMETRIC; SWINE;

EID: 14944380430     PISSN: 03424642     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00134-004-2464-5     Document Type: Article

References (40)

1. Lotze A, Mitchell BR, Bulas DI, Zola EM, Shalwitz RA, Gunkel JH, and the Survanta in Term Infants Group (1998) Multicenter study of surfactant (beractant) use in the treatment of term infants with severe respiratory failure. J Pediatr 132:40-47
2. LeVine AM, Lotze A, Stanley S, Stroud C, O'Donnell R, Whitsett J, Pollack MM (1996) Surfactant content in children with inflammatory lung disease. Crit Care Med 24:1062-1067
3. Marraro GA, Luchetti M, Galassini EM, Abbiati G (1999) Natural surfactant supplementation in ARDS in pediatric age. Minerva Anestesiol 65:92-97
4. Bernard GR, Artigas A, Brigham KL, Carlet J, Falke K, Hudson L, Lamy M, Legall JR, Morris A, Spragg R (1994) The American-European Consensus Conference on ARDS. Definitions, mechanisms, relevant outcomes, and clinical trial coordination. Am J Respir Crit Care Med 149:818-824
5. Anderson MR (2003) Update on pediatric respiratory distress syndrome. Respir Care 48:261-276
6. Rossi AG, Haslett C (1998) Inflammation, cell injury, and apoptosis. In: Said SI (ed) Proinflammatory and antiinflammatory peptides. Lung biology in health and disease. Marcel Dekker, New York, pp 9-24
7. Ware LB, Matthay MA (2000) The acute respiratory distress syndrome. N Engl J Med 342:1334-1349
8. Vaddi K, Keller M, Newton RC (1997) The chemokine factsbook. Academic Harcourt Brace, San Diego, pp 23-37
9. Meduri GU, Headley S, Kohler G, Stentz F, Tolley E, Umberger R, Leeper K (1995) Persistent elevation of inflammatory cytokines predicts a poor outcome in ARDS. Plasma IL-1beta and IL-6 levels are consistent and efficient predictors of outcome over time. Chest 107:1062-1073
10. Meduri GU, Kohler G, Headley S, Tolley E, Streutz F, Postlethwaite A (1995) Inflammatory cytokines in the BAL of patients with ARDS; persistent elevation over time predicts poor outcome. Chest 108:1303-1314
11. Kurdowska A, Miller EJ, Noble JM, Baughman RP, Matthay MA, Brelsford WG, Cohen AB (1996) Anti-IL-8 autoantibody in alveolar fluid from patients with the adult respiratory distress syndrome. J Immunol 157:2699-2706
12. Sekido N, Mukaida N, Harada A, Nakanishi I, Watanabe Y, Matsushima K (1993) Prevention of lung reperfusion injury in rabbits by a monoclonal antibody against interleukin-8. Nature 365:654-657
13. Mulligan MS, Jones ML, Bolanowski MA, Baganoff MP, Deppeler CL, Meyers DM, Ryan US, Ward PA (1993) Inhibition of lung inflammatory reactions in rats by an anti-human IL-8 antibody. J Immunol 150:5585-5595
14. Folkesson HG, Matthay MA, Hebert C, Broaddus VC (1995) Acid aspiration-induced lung injury in rabbits is mediated by IL-8 dependent mechanisms. J Clin Invest 96:107-116
15. Yokoi K, Mukaida N, Harada A, Watanabe Y, Matsushima K (1997) Prevention of endotoxemia-induced acute respiratory distress syndrome-like lung injury in rabbits by a monoclonal antibody to IL-8. Lab Invest 76:375-384
16. Nakamura M, Fujishima S, Sawafuji M, Ishizaka A, Oguma T, Soejima K, Matsubara H, Tasaka S, Kikuchi K, Kobayashi K, Ikeda E, Sadick M, Hebert CA, Aikawa N, Kanazawa M, Yamaguchi K (2000) Importance of interleukin-8 in the development of reexpansion lung injury in rabbits. Am J Respir Crit Care Med 161:1030-1036
17. Andersson U, Bird G, Britton S, Palacios R (1981) Humoral and cellular immunity in humans studied at the cell level from birth to two years of age. Immunological Rev 57:5-38
18. Metinko A (2004) Neonatal pulmonary host defense mechanisms. In: Polin RA, Fox WW, Abman SH (eds) Fetal and neonatal physiology. Saunders, Philadelphia, pp 1620-1673
19. Lachmann B, Robertson B, Vogel J (1980) In vivo lung lavage as an experimental model of the respiratory distress syndrome. Acta Anaesthesiol Scand 24:231-236
20. Krause MF, Hoehn T (1999) Decrease in lung volume depends on end-expiratory pressure in a rabbit model of airway lavage. Respiration 66:259-264
21. Krause MF, Schulte-Mönting J, Hoehn T (1998) Rate of surfactant administration influences lung function and gas exchange in a surfactant-deficient rabbit model. Pediatr Pulmonol 25:196-204
22. Van der Bleek J, Plötz F, Van Overbeek F, Heikamp A, Beekhuis H, Wildevuur C, Okken A, Bambang Oetomo S (1993) Distribution of exogenous surfactant in rabbits with severe respiratory failure: the effect of volume. Pediatr Res 34:154-158
23. Krause MF, Jäkel C, Haberstroh J, Schulte-Mönting J, Leititis JU, Orlowska-Volk M (2001) Alveolar recruitment promotes homogenous surfactant distribution in a piglet model of lung injury. Pediatr Res 50:34-43
24. Schiffmann H, Erdlenbruch B, Singer D, Singer S, Herting E, Hoeft A, Buhre W (2002) Assessment of cardiac output, intravascular volume status, and extravascular lung water by transpulmonary indicator dilution in critically ill neonates and infants. J Cardiothorac Vasc Anesth 16:592-597
25. Scholtes U, Wiegand N, Zwirner J, Herting E (2002) Influence of porcine natural modified surfactant on chemotaxis and oxidative metabolism of polymorphonuclear leukocytes. Immunobiol 205:290-302
26. Schröder JM, Mrowietz U, Morita E, Christophers E (1987) Purification and partial biochemical characterization of a human monocyte-derived, neutrophil-activating peptide that lacks interleukin 1 activity. J Immunol 139:3474-3483
27. Baughman RP, Henderson RF, Whitsett J, Gunther KL, Keeton DA, Waide JJ, Zaccardelli DS, Pattishall EN, Rashkin MC (2002) Surfactant replacement for ventilator-associated pneumonia: a preliminary report. Respiration 69:57-62
28. Ikegami M, Jobe AH (2002) Injury responses to different surfactants in ventilated premature lamb lungs. Pediatr Res 51:689-695
29. Ali H, Richardson RM, Haribabu B, Snyderman R (1999) Chemoattractant receptor cross-desensitization. J Biol Chem 274:6027-6030
30. Nakamura H, Yoshimura K, Jaffe HA, Crystal RG (1991) Interleukin-8 gene expression in human bronchial epithelial cells. J Biol Chem 266:19611-19617
31. Rolfe MW, Kunkel SL, Standiford TJ, Chensue SW, Allen RM, Evanoff HL, Phan SH, Strieter RM (1991) Pulmonary fibroblast expression of interleukin-8: a model for alveolar macrophage-derived cytokine networking. Am J Respir Cell Mol Biol 5:493-501
32. Chollet-Martin S, Jourdain B, Gibert C, Elbim C, Chastre J, Gougerot-Pocidalo MA (1996) Interactions between neutrophils and cytokines in blood and alveolar spaces during ARDS. Am J Respir Crit Care Med 153:594-601
33. Kiehl MG, Ostermann H, Thomas M, Muller C, Cassens U, Kienast J (1998) Inflammatory mediators in bronchoalveolar lavage fluid and plasma in leukocytopenic patients with septic shock-induced acute respiratory distress syndrome. Crit Care Med 26:1194-1199
34. Shute JK, Vrugt B, Lindley IJD, Holgate ST, Bron A, Aalbers R, Djukanovic R (1997) Free and complexed interleukin-8 in blood and bronchial mucosa in asthma. Am J Respir Crit Care Med 155:1877-1883
35. Takasaki J, Ogawa Y (2001) Anti-interleukin-8 autoantibody in the tracheobronchial aspirate of infants with chronic lung disease. Pediatr Int 43:48-52
36. Takasaki J, Ogawa Y (2000) Anti-IL-8 autoantibodies in the tracheobronchial aspirate of infants in the development of chronic lung disease. Acta Neonatol Jpn 36:1-5
37. Nielsen JB, Sjöstrand UH, Edgren EL, Lichtwarck-Aschoff M, Svensson BA (1991) An experimental study of different ventilatory modes in piglets in severe respiratory distress induced by surfactant depletion. Intensive Care Med 17:225-233
38. Von der Hardt K, Kandler MA, Fink L, Schoof E, Dötsch J, Brandenstein O, Bohle RM, Rascher W (2004) High frequency oscillatory ventilation suppresses inflammatory response in lung tissue and microdissected alveolar macrophages in surfactant depleted piglets. Pediatr Res 55:339-346
39. Rotta AT, Gunnarsson B, Fuhrman BP, Hernan LJ, Steinhorn DM (2001) Comparison of lung protective ventilation strategies in a rabbit model of acute lung injury. Crit Care Med 29:2176-2184
40. Suh GY, Koh Y, Chung MP, An CH, Kim H, Jang WY, Han J, Kwon OJ (2002) Repeated derecruitments accentuate lung injury during mechanical ventilation. Crit Care Med 30:1848-1853